PI
Amsterdam institute for Immunology and Infectious Diseases
-
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study
Simon, T. A., Suissa, S., Skovron, M. L., Frisell, T., Askling, J., Michaud, K., Pedro, S., Strangfeld, A., Meissner, Y., Boers, M., Hoffman, V., Dominique, A., Gomez, A. & Hochberg, M. C., Feb 2024, In: Seminars in Arthritis and Rheumatism. 64, 152313.Research output: Contribution to journal › Article › Academic › peer-review
-
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study
Simon, T. A., Suissa, S., Boers, M., Hochberg, M. C., Skovron, M. L., Askling, J., Michaud, K., Strangfeld, A., Pedro, S., Frisell, T., Meissner, Y., Dominique, A. & Gomez, A., Feb 2024, In: Seminars in Arthritis and Rheumatism. 64, 152240.Research output: Contribution to journal › Article › Academic › peer-review
-
Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis
Kerstens, F., Spijkers, K., Wolthuis, D., Boers, M., van Herwaarden, N. & ten Cate, D., 1 Jan 2024, In: Rheumatology (Oxford, England). 63, 1, p. e15-e16Research output: Contribution to journal › Letter › Academic › peer-review
- All publications